Columbia-based Martek Biosciences Corp. has reported a sales increase of 166% of its nutritional oils for infant formula, from US$1.9m to US$4.9m, for Q3 this year.
Go deeper with GlobalData
In the same period, the three months ending 31 July, revenue more than doubled, from US$2.5m to US$5.6m.
Martek produces nutritional products from microalgae, and the oils are licensed to many major infant formula markers, who sell products in over 60 countries.
In May, the US Food and Drug Administration (FDA) approved the use of Martek’s nutritional oils in infant formula for sale in the US.
The company added that the enormous sales growth helped narrow its Q3 loss, to US$3.3m, down from US$3.8m for the same quarter the previous year.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
